| 11912681 |
Crystalline and salt forms of PPAR agonist compounds |
Bharat Lagu |
2024-02-27 |
| 11530192 |
Crystalline and salt forms of PPAR agonist compounds |
Bharat Lagu |
2022-12-20 |
| 10927094 |
Crystalline and salt forms of PPAR agonist compounds |
Bharat Lagu |
2021-02-23 |
| 10577348 |
(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations |
Pranav Gupta, Jason Wan |
2020-03-03 |
| 10035796 |
Crystalline forms of a BACE inhibitor, compositions, and their use |
Irina Kazakevich, Tao Feng |
2018-07-31 |
| 10017505 |
Crystalline forms of a BACE inhibitor, compositions, and their use |
Zachary E. Dance, Yong Liu, Richard J. Varsolona, Gregory York |
2018-07-10 |
| 9604971 |
Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin |
Alicia V. Duran-Capece, Matthew Lamm |
2017-03-28 |
| 8680294 |
Enantio- and stereo specific synthesis of β-amino-α-hydroxy amides |
John F. Traverse, William M. Leong, Steven P. Miller, Jennifer Albaneze-Walker, Thomas J. Hunter +15 more |
2014-03-25 |
| 7956189 |
Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore |
Xiaoming Chen, Xiao-Tao Chen, Jianguo Yin, Xiaoyong Fu, David J. Blythin +5 more |
2011-06-07 |
| 7919505 |
Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
Pauline C. Ting, Joe F. Lee, Kung-I Feng, Michael R. Reeder, Man Zhu +3 more |
2011-04-05 |
